Xintela AB (Sweden) Today
| XINT Stock | SEK 0.32 0.03 8.57% |
Performance0 of 100
| Odds Of DistressOver 88
|
Xintela AB is selling for under 0.32 as of the 26th of November 2024; that is 8.57 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.32. Xintela AB has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Xintela AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of July 2023 and ending today, the 26th of November 2024. Click here to learn more.
Xintela AB , a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage damage and brain tumors. The company was founded in 2009 and is based in Lund, Sweden. Xintela AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. The company has 307.57 M outstanding shares. More on Xintela AB
Moving together with Xintela Stock
| 0.83 | CAMX | Camurus AB | PairCorr |
| 0.91 | HNSA | Hansa Biopharma AB | PairCorr |
| 0.91 | NANOFS | Nanoform Finland Plc | PairCorr |
Moving against Xintela Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Xintela Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Xintela AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Xintela AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Xintela AB (XINT) is traded on Stockholm Exchange in Sweden and employs 16 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 143.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Xintela AB's market, we take the total number of its shares issued and multiply it by Xintela AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Xintela AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 307.57 M outstanding shares.
Xintela AB has accumulated about 11.14 M in cash with (42.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Xintela AB Probability Of Bankruptcy
Ownership AllocationXintela AB retains a total of 307.57 Million outstanding shares. Xintela AB owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Xintela Ownership Details
Xintela AB Risk Profiles
Although Xintela AB's alpha and beta are two of the key measurements used to evaluate Xintela AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.91 | |||
| Standard Deviation | 3.96 | |||
| Variance | 15.72 | |||
| Risk Adjusted Performance | (0.09) |
Xintela Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Xintela AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Additional Tools for Xintela Stock Analysis
When running Xintela AB's price analysis, check to measure Xintela AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xintela AB is operating at the current time. Most of Xintela AB's value examination focuses on studying past and present price action to predict the probability of Xintela AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xintela AB's price. Additionally, you may evaluate how the addition of Xintela AB to your portfolios can decrease your overall portfolio volatility.